Zimmer Biomet 2016 Revenue
ORTHOWORLD estimates Zimmer Biomet 2016 orthopaedic revenue of US $7,100.9MM, +3.2% from 2015, with 4Q16 revenue of $1,873.4MM, +5.9% vs. 4Q15.
ORTHOWORLD estimates 2016 segment sales and growth on an as-reported basis, as follows.
- Joint Reconstruction $5,012.5MM, +1.4%
- Hip $1,867.9MM, +1.5%
- Knee $2,751.9MM, +0.6%
- Extremities $392.7MM, +5.9%
- Trauma $536.3MM, +6.8%
- Arthroscopy/Soft Tissue $124.2MM, +8.1%
- Spine $338.6MM, +15.6% (includes acquisition)
- Orthobiologics $284.0MM, +3.2%
- Other $805.2MM, +7.0% (CMF, Bone Healing, Forgings and Accelero)
Growth supported by acquisitions such as LDR (with the Mobi-C cervical disc) and Cayenne Medical (bolstering revenue in sports medicine with soft tissue repair offerings)
Additionally, performance buoyed by reacceleration of core knee and hip sales and strength in the company’s reported S.E.T. (Surgical, Sports Medicine, Foot/Ankle, Extremities and Trauma) category in the Asia Pacific region
Intelligent instrumentation portfolio deployed in nearly 100,000 cases in 2016 (including Signature Solutions, patient-specific instruments, iASSIST technology, eLibra, etc.)
On track for 2017 launch of Signature Solutions (“further unveiling” slated for AAOS meeting)
During 4Q, acquired the RespondWell Telerehabilitation platform for patient use with Signature Solutions
In answering analyst queries on response to SYK’s data collection efforts for the Mako knee application, leadership did not specifically describe studies to be performed on Personalized Solutions and Signature Solutions offerings, but recapped the benefits of early patient engagement, optimized pre-op practices, etc.
Pricing update for 4Q: Knees -1.9% (positive volume/mix of 3.7%), hips -2.3% (positive volume/mix of 5.2%)
4Q sales supported by Oxford Partial knee; G7 Acetabular System and G7 Dual Mobility Construct, Taperloc Complete, Arcos Femoral Revision; Subchondroplasty; Gel-One Crosslinked Hyaluronate injection; increased demand for Comprehensive Total Shoulder and Nexel Total Elbow; steady sales of NCB Femur Plate, AFFIXUS Hip Nail and DVR Crosslock Distal Radius Plate
Leadership noted acceleration of Vitality Spinal Fixation system
Investing $170MM to harmonize/optimize supply chain, manufacturing and quality systems
Regarding supply chain constraints, operational process improvements are underway at a major production facility; affected products may experience distribution delays
Submitted written response to FDA’s Form 483 observations; remediation work will continue into next year
Within the last quarter of 2016, entered into distribution agreements for Nextremity Solutions products and Seikagaku’s VISCO-3
Sources: Zimmer Biomet, Inc.; ORTHOWORLD Inc.